
About FastDetect
FastDetect is a Healthcare company based in Pasadena (United States) founded in 2003. Smart testing devices for infectious disease detection are developed. Its focus areas include Life Sciences, Infectious Diseases, Medical Devices and Screening. Its competitors include PIMMAP and Pears Health Americas.
Company details
FastDetect was founded in 2003 in Pasadena, United States, and operates in the medical diagnostics sector. Smart testing devices for detecting infectious diseases, including coronaviruses, are produced using patented qPCR solenoid-based thermal cycling technology. The FD-1 instrument employs RT-PCR methods to analyze pathogen genetic material and generate infection reports. HIPAA-compliant software is provided to manage instrument operations, store data, and transmit results to relevant parties.
- Headquarters Pasadena, United States
- SectorsHealthcare
- Website fastdetect.com
- Social LinkedIn
- Investors
Funding Insights of FastDetect
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of FastDetect with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | Seed | β | β |
1 investors in total: 1 institutional.
Investors in FastDetect
FastDetect has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Wavemaker Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| wavemaker.vc |
Investor details for FastDetect
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of FastDetect
2 people are tracked at FastDetect (2 in leadership).
| Name | Role | Group |
|---|---|---|
Jim Demetriades | Chairman and CEO | Leadership |
Erika Garcia | Head of Biochemistry, Co-Founder | Leadership |
Complete people profiles for FastDetect
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of FastDetect
2 dated milestones of FastDetect across 18 years, from founding to its latest funding, stage changes and deals.
- Founded FastDetect is founded.
- Funding First funding round.
Competitors of FastDetect
FastDetect has 2 listed competitors in our database. They include PIMMAP and Pears Health Americas.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pimmap.com | 2020 | Carlstadt, United States | Offers interactive video brochures, ads, and displays for business marketing. | |||
| pearshealthamericas.com | 2020 | Charlottesville, United States | Develops and markets wearable thermometers for health tracking via mobile apps. |
Detailed competitors of FastDetect
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Infectious Diseases
3 companies that operate in the same segment as FastDetect (Infectious Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about FastDetect
FastDetect was founded in 2003 and raised its 1st funding round 18 years after it was founded.
FastDetect is headquartered in Pasadena, United States. It is registered at Pasadena, California, United States.
FastDetect was founded in 2003 in Pasadena, United States, and operates in the medical diagnostics sector. Smart testing devices for detecting infectious diseases, including coronaviruses, are produced using patented qPCR solenoid-based thermal cycling technology. The FD-1 instrument employs RT-PCR methods to analyze pathogen genetic material and generate infection reports. HIPAA-compliant software is provided to manage instrument operations, store data, and transmit results to relevant parties.
FastDetect's top competitors include PIMMAP and Pears Health Americas.
FastDetect has 1 investor. Key investors include Wavemaker Partners.